FR2110465A1 - - Google Patents

Info

Publication number
FR2110465A1
FR2110465A1 FR7137199A FR7137199A FR2110465A1 FR 2110465 A1 FR2110465 A1 FR 2110465A1 FR 7137199 A FR7137199 A FR 7137199A FR 7137199 A FR7137199 A FR 7137199A FR 2110465 A1 FR2110465 A1 FR 2110465A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7137199A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Merrell SpA
Original Assignee
Richardson Merrell SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell SpA filed Critical Richardson Merrell SpA
Publication of FR2110465A1 publication Critical patent/FR2110465A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7137199A 1970-10-15 1971-10-15 Withdrawn FR2110465A1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8093670A 1970-10-15 1970-10-15

Publications (1)

Publication Number Publication Date
FR2110465A1 true FR2110465A1 (el) 1972-06-02

Family

ID=22160611

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7137199A Withdrawn FR2110465A1 (el) 1970-10-15 1971-10-15

Country Status (9)

Country Link
AU (1) AU3460571A (el)
BE (1) BE773910A (el)
DE (1) DE2150900A1 (el)
FR (1) FR2110465A1 (el)
GB (1) GB1310658A (el)
IL (1) IL37904A0 (el)
NL (1) NL7114199A (el)
PH (1) PH12920A (el)
ZA (1) ZA716628B (el)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059775A2 (de) * 1980-06-09 1982-09-15 Leopold & Co. Chem. pharm. Fabrik Gesellschaft m.b.H. Infusionslösung zum Schutz der Leber und zur Verbesserung von deren Funktion und Verfahren zu deren Herstellung
WO1988001865A1 (en) * 1986-09-17 1988-03-24 Natural Vitality Limited Amino acid composition
EP0318891A1 (de) * 1987-12-04 1989-06-07 ASTA Medica Aktiengesellschaft Injizierbare Lösung des Thioctsäuresalzes mit Trometamol und/oder basischen Aminosäuren
FR2653997A1 (fr) * 1989-11-09 1991-05-10 Asta Pharma Ag Medicaments contenant comme sunstances actives des acides carboxyliques soufres, leur preparation et leur utilisation pour lutter contre les retrovirus.
FR2791571A1 (fr) * 1999-04-02 2000-10-06 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
WO2007040244A1 (ja) * 2005-10-04 2007-04-12 Kyowa Hakko Kogyo Co., Ltd. 疲労自覚症状改善用組成物

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486429B2 (en) 1999-06-01 2016-11-08 Vanderbilt University Therapeutic methods employing nitric oxide precursors
US6346382B1 (en) 1999-06-01 2002-02-12 Vanderbilt University Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
US20020006907A1 (en) * 2000-02-01 2002-01-17 Paul Gardiner Alpha lipoic acid based food supplement for increasing lean muscle mass and strength
JP3907964B2 (ja) * 2001-04-25 2007-04-18 株式会社 伊藤園 精神疲労軽減組成物、集中力維持増強組成物及び精神的活力維持増強組成物
MXPA04011776A (es) * 2002-05-29 2005-03-31 Unilever Nv Control de olor en composiciones cosmeticas conteniendo sal de amina.
PT2153870E (pt) 2004-11-26 2014-03-12 Ucl Business Plc Composições compreendendo ornitina e fenilacetato ou fenilbutirato para tratamento de encefalopatia hepática
US20100137226A1 (en) * 2006-06-07 2010-06-03 Kyowa Hakko Bio Co., Ltd Fatigue-reducing agent
US8945655B2 (en) 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
JP5623916B2 (ja) 2008-01-31 2014-11-12 バンダービルト・ユニバーシティＶａｎｄｅｒｂｉｌｔ Ｕｎｉｖｅｒｓｉｔｙ 動脈瘤性くも膜下出血及び血管痙攣に対する医薬組成物
EA023051B1 (ru) 2009-04-03 2016-04-29 Осера Терапьютикс, Инк. Кристаллические формы фенилацетата l-орнитина и их применение
EP2799067B1 (en) 2009-06-08 2019-04-03 UCL Business PLC Treatment of brain inflammation using L-Ornithine Phenylacetate
BR112013008054B1 (pt) 2010-10-06 2019-04-09 Ocera Therapeutics, Inc. Composição e processo para produção de sal de acetato de fenil l-ornitina
BR112017010761B1 (pt) 2014-11-24 2022-10-18 Ucl Business Plc Tratamento de doenças associadas à ativação de célula estrelada hepática com o uso de terapias de redução de amônia
CA2995823A1 (en) 2015-08-18 2017-02-23 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
JP7126520B2 (ja) 2017-05-11 2022-08-26 オセラ セラピューティクス， インコーポレイテッド Ｌ－オルニチンフェニルアセテートを製造する方法

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059775A2 (de) * 1980-06-09 1982-09-15 Leopold & Co. Chem. pharm. Fabrik Gesellschaft m.b.H. Infusionslösung zum Schutz der Leber und zur Verbesserung von deren Funktion und Verfahren zu deren Herstellung
EP0059775A3 (en) * 1980-06-09 1982-10-27 Leopold & Co. Chem. Pharm. Fabrik Gesellschaft M.B.H. Infusion solution for the protection of the liver and the improvement of its functioning, and process for its production
WO1988001865A1 (en) * 1986-09-17 1988-03-24 Natural Vitality Limited Amino acid composition
EP0318891A1 (de) * 1987-12-04 1989-06-07 ASTA Medica Aktiengesellschaft Injizierbare Lösung des Thioctsäuresalzes mit Trometamol und/oder basischen Aminosäuren
FR2653997A1 (fr) * 1989-11-09 1991-05-10 Asta Pharma Ag Medicaments contenant comme sunstances actives des acides carboxyliques soufres, leur preparation et leur utilisation pour lutter contre les retrovirus.
EP0427246A2 (de) * 1989-11-09 1991-05-15 ASTA Medica Aktiengesellschaft Arzneimittel, welche als Wirkstoff Schwefel enthaltende Carbonsäuren enthalten sowie deren Verwendung zur Bekämpfung von Retroviren
GR900100796A (en) * 1989-11-09 1992-04-17 Asta Pharma Ag Method for preparing compounds comprising as an active substance carbonic acids containing sulphur and application therefor against retrovirus
EP0427246A3 (en) * 1989-11-09 1992-06-03 Asta Pharma Ag Pharmaceutical compositions comprising sulfur containing carboxylic acids as the active agent as well as their use for combatting retroviruses
BE1003834A5 (fr) * 1989-11-09 1992-06-23 Asta Medica Ag Medicaments qui contiennent, comme substance active, des acides carboxyliques contenant du soufre, ainsi que leur utilisation pour lutter contre des retrovirus.
GR1001503B (el) * 1989-11-09 1994-02-28 Asta Pharma Ag Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
FR2791571A1 (fr) * 1999-04-02 2000-10-06 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
WO2000059448A2 (fr) * 1999-04-02 2000-10-12 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Association d'inhibiteur(s) de no synthase et d'antioxydant(s) metabolique(s)
WO2000059448A3 (fr) * 1999-04-02 2001-03-08 Sod Conseils Rech Applic Association d'inhibiteur(s) de no synthase et d'antioxydant(s) metabolique(s)
WO2007040244A1 (ja) * 2005-10-04 2007-04-12 Kyowa Hakko Kogyo Co., Ltd. 疲労自覚症状改善用組成物
US7932288B2 (en) 2005-10-04 2011-04-26 Kyowa Hakko Bio Co., Ltd. Composition for relieving subjective symptoms of fatigue
JP5210636B2 (ja) * 2005-10-04 2013-06-12 協和発酵バイオ株式会社 疲労自覚症状改善用組成物

Also Published As

Publication number Publication date
PH12920A (en) 1979-10-10
NL7114199A (el) 1972-04-18
AU3460571A (en) 1973-04-19
IL37904A0 (en) 1971-12-29
ZA716628B (en) 1972-06-28
GB1310658A (en) 1973-03-21
DE2150900A1 (de) 1972-04-20
BE773910A (fr) 1972-01-31

Similar Documents

Publication Publication Date Title
AR204384A1 (el)
ATA96471A (el)
AU1146470A (el)
AU3330871A (el)
AU1473870A (el)
AU1833270A (el)
AU1716970A (el)
AU1517670A (el)
AU1336970A (el)
AU1326870A (el)
AR195465A1 (el)
AU2144270A (el)
AU1603270A (el)
AU1974970A (el)
AU1189670A (el)
AU1235770A (el)
AU1247570A (el)
AU1918570A (el)
AU1969370A (el)
AU1943370A (el)
AU1328670A (el)
AU1086670A (el)
AU1343870A (el)
AU1083170A (el)
AU1277070A (el)

Legal Events

Date Code Title Description
ST Notification of lapse